Newest Titles

• Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
  Article (Journal), Online Resource
• CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
  Article (Journal), Online Resource
• A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
  Article (Journal), Online Resource
• Metabolic effect of blocking sodium-taurocholate co-transporting polypeptide in hypercholesterolemic humans with a twelve-week course of bulevirtide: n exploratory phase I clinical trial
  Article (Journal), Online Resource
• Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
  Article (Journal), Online Resource

see all (5)
Alle anzeigen (incl. other editions/formats) (6)

Related Authors

• Benner, Axel
• Goldschmidt, Hartmut
• Raab, Marc-Steffen
• Bertsch, Uta
• Hose, Dirk

see all (72)

Publication Timeline

Publication Formats